
Uncategorized
1 March 2022
Amyloidosis, a rare disease studied in Limoges – France 3 TV report
Amyloidosis is caused by blood cells that produce abnormal proteins, which form “fibrils”, a clump of proteins. They aggregate [...]

Uncategorized
10 December 2021
Allergies: spotlight on an RNA treatment
Some allergies – respiratory, food or drugs are caused by the release into the bloodstream of specific antibodies, immunoglobulinE [...]

Uncategorized
29 October 2021
Publication dans British Journal of Cancer : Preclinical study of 212Pb-radioimmunotherapy targeting CD20 in Non-Hodgkin Lymphoma.
The CARAT project “Consortium for Applications in Radio Alpha Therapies”, funded by BPI France, aimed to carry out preclinical studies with [...]

Uncategorized | Uncategorized | Uncategorized | Uncategorized | Uncategorized | Uncategorized | Uncategorized | Uncategorized | Uncategorized | Uncategorized | Seminar
29 October 2021
Double blow for the 2MB2C team in Lyon at the 7th Filo Days
At the CRIBL UMR CNRS 7276 / INSERM 1262 laboratory in Limoges, we are interested in the mechanisms involved in the appearance of these two [...]

19 October 2021
Obtaining ANR fundings
CRIBL has obtained 2 fundings from the Agence Nationale de la Recherche. This aid aims to promote the pooling of skills and resources from [...]

27 September 2021
Signature of a co-education agreement between the University of Limoges and Inserm
On Tuesday, September 14th, the University of Limoges signed a co-education agreement with Inserm. By this agreement, the two establishments [...]

Uncategorized
27 September 2021
Microscoop #84 : When antibodies become toxic
In all the defense mechanisms that the human body triggers to fight against external aggression, antibodies are at the forefront. When they [...]

Uncategorized
12 July 2021
Curieux! Live : All about antibodies
Curieux ! is an information site that fits into our daily lives to disentangle truth from falsehood and sharpen our curiosity. In this [...]

Uncategorized
8 July 2021
Participation of CRIBL at the days of interdisciplinarity – University of Limoges
The University of Limoges is a multidisciplinary university in which subjects of human and social sciences, sciences and techniques, life [...]

Uncategorized
8 July 2021
Participation of CRIBL at the 3rd European B Cell Forum
The 3rd European B Cell Forum took place from June 30 to July 2. On this occasion, the specialists discussed the latest advances in the [...]

Uncategorized | Press | Press | Press | Press | Press
7 July 2021
France Bleu Limousin podcast on the therapeutic protein SAP-Fc
Find a France Bleu Limousin podcast on the creation of a therapeutic protein to treat amyloidosis and in particular AL amyloidosis, which [...]

18 June 2021
Review on monoclonal gammopathies of renal significance published in New England Journal of Medecine (IF 74.699)
Frank Bridoux, head of the nephrology service at CHU Poitiers and member of the team led by Christophe Sirac, recently published in the [...]